암 온열요법 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)
Hyperthermia Treatment for Cancer Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
상품코드:1585104
리서치사:Persistence Market Research
발행일:2024년 11월
페이지 정보:영문 121 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 암 온열요법 시장에 대해 조사했으며, 기기 유형별, 최종사용자별, 용도별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.
목차
제1장 개요
제2장 시장 서론
제3장 세계의 암 온열요법 시장 분석 시나리오
가격 분석
시장과 예측
제4장 시장 역학
거시경제 요인
촉진요인
억제요인
기회
예측 요인 - 관련성과 영향
제5장 세계의 암 온열요법 시장 분석과 예측 : 기기 유형별
서론
BPS(Basis Point Share) 분석 : 기기 유형별
전년대비 성장 예측 : 기기 유형별
시장가치 예측 : 기기 유형별
시장의 매력 : 기기 유형별
제6장 세계의 암 온열요법 시장 분석과 예측 : 최종사용자별
서론
BPS(Basis Point Share) 분석 : 최종사용자별
전년대비 성장 예측 : 최종사용자별
시장가치 예측 : 최종사용자별
시장의 매력 : 최종사용자별
제7장 세계의 암 온열요법 시장 분석과 예측 : 용도별
서론
BPS(Basis Point Share) 분석 : 용도별
전년대비 성장 예측 : 용도별
시장가치 예측 : 용도별
시장의 매력 : 용도별
제8장 세계의 암 온열요법 시장 분석과 예측 : 지역별
BPS(Basis Point Share) 분석 : 지역별
전년대비 성장 예측 : 지역별
시장가치 예측 : 지역별
시장의 매력 : 지역별
제9장 북미의 암 온열요법 시장 분석과 예측
제10장 유럽의 암 온열요법 시장 분석과 예측
제11장 라틴아메리카의 암 온열요법 시장 분석과 예측
제12장 아시아태평양의 암 온열요법 시장 분석과 예측
제13장 중동 및 아프리카의 암 온열요법 시장 분석과 예측
제14장 경쟁 구도
경쟁 대시보드
기업 개요(상세 - 개요, 재무, 전략, 최근 동향)
Celsius42+GmbH
Pyrexar Medical Inc.
Oncothermia
Hydrosun GmbH
Yamamoto Vinita Co., Ltd
Andromedic Srl
Haifu Medical Technology Co. Ltd
제15장 사용되는 전제 조건과 두자어
제16장 조사 방법
KSA
영문 목차
영문목차
Persistence Market Research has recently released a comprehensive report on the global Hyperthermia Treatment for Cancer Market, providing an in-depth analysis of key market dynamics, including driving factors, emerging trends, opportunities, and challenges. This report delivers a detailed understanding of the market landscape, offering valuable insights to help stakeholders make informed decisions.
Global Market Growth Rate (CAGR 2024 to 2031): 5.9%
Hyperthermia Treatment for Cancer Market - Report Scope:
The Hyperthermia Treatment for Cancer market involves treatments that use high temperatures to target cancer cells, either alone or in combination with other therapies like chemotherapy and radiation. Techniques include local, regional, and whole-body hyperthermia, with applications across various cancer types. The market is driven by an increasing incidence of cancer globally, growing demand for minimally invasive treatments, and advancements in hyperthermia technologies. Hyperthermia is known to enhance the effects of radiation and chemotherapy, providing a promising complementary treatment option for cancer patients.
Market Growth Drivers:
Several factors are driving the growth of the global Hyperthermia Treatment for Cancer market, including the rising cancer prevalence worldwide, technological advancements in hyperthermia systems, and increasing awareness of its benefits as an adjunctive treatment. An increased focus on personalized cancer therapies and the shift towards non-invasive treatment options further propel market expansion. Growing healthcare investments and supportive government policies in oncology treatment are also facilitating market growth.
Market Restraints:
The Hyperthermia Treatment for Cancer market faces challenges, such as high equipment costs, limited availability of specialized treatment centers, and a need for trained professionals. The lack of standardized treatment protocols and potential side effects associated with hyperthermia therapy, including skin irritation and burns, may impact adoption. Additionally, limited awareness of hyperthermia treatment options in some regions and restricted insurance coverage pose challenges to market growth. Addressing these issues involves increasing access to equipment and improving awareness among healthcare providers and patients.
Market Opportunities:
Significant opportunities exist in the Hyperthermia Treatment for Cancer market as new technological developments make treatments more accessible and effective. Advancements in precision hyperthermia techniques, such as microwave and ultrasound hyperthermia, are opening new avenues for treatment. Collaboration between healthcare providers and equipment manufacturers, along with partnerships for clinical trials and research, is expected to drive innovation and expand treatment adoption. Increasing demand in emerging economies, driven by rising healthcare infrastructure and investment, also presents substantial growth opportunities.
Key Questions Answered in the Report:
What are the primary factors driving growth in the global Hyperthermia Treatment for Cancer market?
Which hyperthermia treatment techniques are seeing the highest demand across different cancer types?
How are technological advancements in hyperthermia systems impacting the competitive landscape?
Who are the major players in the Hyperthermia Treatment for Cancer market, and what strategies are they implementing to stay competitive?
What are the emerging trends and future prospects for the global Hyperthermia Treatment for Cancer market?
Competitive Intelligence and Business Strategy:
Leading companies in the global Hyperthermia Treatment for Cancer market, such as Pyrexar Medical Inc., Celsius42 GmbH, and ThermoChem Inc., are focusing on technological advancements, product differentiation, and strategic partnerships to strengthen their market positions. These companies invest heavily in research and development to enhance treatment precision, efficiency, and safety. Collaborations with oncology centers, clinical trials, and distribution partnerships are crucial for expanding market reach. Emphasizing patient-centered care, cost-effectiveness, and technological innovations are key strategies to maintain a competitive edge in this specialized market.
Key Companies Profiled:
Pyrexar Medical Inc.
Celsius42 GmbH
ThermoChem Inc.
Andromedic Srl
SIRIO Medical Devices
Oncotherm Ltd.
BSD Medical Corporation
Yamamoto Vinita Co., Ltd.
Perseon Corporation
Hyperthermia Treatment for Cancer Industry Research by Category:
By Device Type
Microwave Hyperthermia Device
Ultrasound Hyperthermia Device
Infrared Hyperthermia Device
Short-wave Hyperthermia Device
By End User
Hospitals
Clinics
Research Institutes
Cancer Centers
Others
By Application
Breast Cancer
Liver Cancer
Soft Tissue Sarcoma
Leukemia
Head and Neck Tumors
Prostate Cancer
Others
By Region:
North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa
Table of Contents
1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Global Hyperthermia Treatment for Cancer Market Analysis Scenario
3.1. Pricing Analysis
3.1.1. Pricing Assumptions
3.1.2. Price Projections Per Region
3.2. Market Size (US$ Mn) and Forecast
3.2.1. Market Size and Y-o-Y Growth
3.2.2. Absolute $ Opportunity
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Forecast Factors - Relevance and Impact
5. Global Hyperthermia Treatment for Cancer Market Analysis and Forecasts, By Devices Type
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Devices Type
5.3. Y-o-Y Growth Projections By Devices Type
5.4. Market Value Forecast By Devices Type, 2024-2031
5.4.1. Microwave Hyperthermia Device
5.4.2. Ultrasound Hyperthermia Device
5.4.3. Infrared Therapy Device
5.4.4. Short-wave Therapy Device
5.5. Market Attractiveness By Devices Type
6. Global Hyperthermia Treatment for Cancer Market Analysis and Forecasts, By End User
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By End User
6.3. Y-o-Y Growth Projections By End User
6.4. Market Value Forecast By End User, 2024-2031
6.4.1. Hospitals
6.4.2. Clinics
6.4.3. Research Institutes
6.4.4. Cancer Centers
6.4.5. Others
6.5. Market Attractiveness By End User
7. Global Hyperthermia Treatment for Cancer Market Analysis and Forecasts, By Application
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By Application
7.3. Y-o-Y Growth Projections By Application
7.4. Market Value Forecast By Application, 2024-2031
7.4.1. Breast Cancer
7.4.2. Liver cancer
7.4.3. Soft Tissue sarcoma
7.4.4. Leukemia
7.4.5. Head and neck tumors
7.4.6. Prostate Cancer
7.4.7. Others
7.5. Market Attractiveness By Application
8. Global Hyperthermia Treatment for Cancer Market Analysis and Forecasts, By Region
8.1. Basis Point Share (BPS) Analysis By Region
8.2. Y-o-Y Growth Projections By Region
8.3. Market Value Forecast By Region
8.3.1. North America
8.3.2. Europe
8.3.3. Latin America
8.3.4. Asia Pacific
8.3.5. Middle East & Africa
8.4. Market Attractiveness By Region
9. North America Hyperthermia Treatment for Cancer Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.1.3. Key Regulations
9.2. Market Value Forecast By Devices Type, 2024-2031
9.2.1. Microwave Hyperthermia Device
9.2.2. Ultrasound Hyperthermia Device
9.2.3. Infrared Therapy Device
9.2.4. Short-wave Therapy Device
9.3. Market Value Forecast By End User, 2024-2031
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Research Institutes
9.3.4. Cancer Centers
9.3.5. Others
9.4. Market Value Forecast By Application, 2024-2031
9.4.1. Breast Cancer
9.4.2. Liver cancer
9.4.3. Soft Tissue sarcoma
9.4.4. Leukemia
9.4.5. Head and neck tumors
9.4.6. Prostate Cancer
9.4.7. Others
9.5. Market Value Forecast By Country, 2024-2031
9.5.1. US
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Devices Type
9.6.2. By End User
9.6.3. By Application
9.6.4. By Country
9.7. Prominent Trends
10. Europe Hyperthermia Treatment for Cancer Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.1.3. Key Regulations
10.2. Market Value Forecast By Devices Type, 2024-2031
10.2.1. Microwave Hyperthermia Device
10.2.2. Ultrasound Hyperthermia Device
10.2.3. Infrared Therapy Device
10.2.4. Short-wave Therapy Device
10.3. Market Value Forecast By End User, 2024-2031
10.3.1. Hospitals
10.3.2. Clinics
10.3.3. Research Institutes
10.3.4. Cancer Centers
10.3.5. Others
10.4. Market Value Forecast By Application, 2024-2031
10.4.1. Breast Cancer
10.4.2. Liver cancer
10.4.3. Soft Tissue sarcoma
10.4.4. Leukemia
10.4.5. Head and neck tumors
10.4.6. Prostate Cancer
10.4.7. Others
10.5. Market Value Forecast By Country, 2024-2031
10.5.1. Germany
10.5.2. France
10.5.3. Italy
10.5.4. U.K.
10.5.5. Spain
10.5.6. Russia
10.5.7. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Devices Type
10.6.2. By End User
10.6.3. By Application
10.6.4. By Country
10.7. Prominent Trends
11. Latin America Hyperthermia Treatment for Cancer Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.2. Market Value Forecast By Devices Type, 2024-2031
11.2.1. Microwave Hyperthermia Device
11.2.2. Ultrasound Hyperthermia Device
11.2.3. Infrared Therapy Device
11.2.4. Short-wave Therapy Device
11.3. Market Value Forecast By End User, 2024-2031
11.3.1. Hospitals
11.3.2. Clinics
11.3.3. Research Institutes
11.3.4. Cancer Centers
11.3.5. Others
11.4. Market Value Forecast By Application, 2024-2031
11.4.1. Breast Cancer
11.4.2. Liver cancer
11.4.3. Soft Tissue sarcoma
11.4.4. Leukemia
11.4.5. Head and neck tumors
11.4.6. Prostate Cancer
11.4.7. Others
11.5. Market Value Forecast By Country, 2024-2031
11.5.1. Brazil
11.5.2. Mexico
11.5.3. Rest of the Latin America
11.6. Market Attractiveness Analysis
11.6.1. By Devices Type
11.6.2. By End User
11.6.3. By Application
11.6.4. By Country
11.7. Prominent Trends
12. Asia Pacific Hyperthermia Treatment for Cancer Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.2. Market Value Forecast By Devices Type, 2024-2031
12.2.1. Microwave Hyperthermia Device
12.2.2. Ultrasound Hyperthermia Device
12.2.3. Infrared Therapy Device
12.2.4. Short-wave Therapy Device
12.3. Market Value Forecast By End User, 2024-2031
12.3.1. Hospitals
12.3.2. Clinics
12.3.3. Research Institutes
12.3.4. Cancer Centers
12.3.5. Others
12.4. Market Value Forecast By Application, 2024-2031
12.4.1. Breast Cancer
12.4.2. Liver cancer
12.4.3. Soft Tissue sarcoma
12.4.4. Leukemia
12.4.5. Head and neck tumors
12.4.6. Prostate Cancer
12.4.7. Others
12.5. Market Value Forecast By Country, 2024-2031
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Devices Type
12.6.2. By End User
12.6.3. By Application
12.6.4. By Country
12.7. Prominent Trends
13. Middle East & Africa Hyperthermia Treatment for Cancer Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis By Country
13.1.2. Y-o-Y Growth Projections By Country
13.2. Market Value Forecast By Devices Type, 2024-2031
13.2.1. Microwave Hyperthermia Device
13.2.2. Ultrasound Hyperthermia Device
13.2.3. Infrared Therapy Device
13.2.4. Short-wave Therapy Device
13.3. Market Value Forecast By End User, 2024-2031
13.3.1. Hospitals
13.3.2. Clinics
13.3.3. Research Institutes
13.3.4. Cancer Centers
13.3.5. Others
13.4. Market Value Forecast By Application, 2024-2031
13.4.1. Breast Cancer
13.4.2. Liver cancer
13.4.3. Soft Tissue sarcoma
13.4.4. Leukemia
13.4.5. Head and neck tumors
13.4.6. Prostate Cancer
13.4.7. Others
13.5. Market Value Forecast By Country, 2024-2031
13.5.1. South Africa
13.5.2. GCC Countries
13.5.3. Rest of MEA
13.6. Market Attractiveness Analysis
13.6.1. By Devices Type
13.6.2. By End User
13.6.3. By Application
13.6.4. By Country
13.7. Prominent Trends
14. Competition Landscape
14.1. Competition Dashboard
14.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)